Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.

Despite the sizable STEMI cohort, this study may be underpowered to assess clinical outcomes in relation to different modes of prasugrel cessation; in particular, discontinuation was associated with a numerically (1.6‐fold) higher risk of major adverse cardiac events, which nonetheless did not reach statistical significance, likely because of the small numbers of patients and limited numbers of events in each group.

also in 111,027 other papers